NCT05289245招募中不适用
A National Registry on Clinical Manifestations, Genetics, Interventions, and Outcomes in Chinese Patients With Cystic Fibrosis (CF-CHINA)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Change in spirometry (FEV1 and FVC) of lymphangioleiomyomatosis patients.
研究概览
简要总结
Cystic fibrosis (CF) is a rare autosomal recessive disease involving multiple organs, especially the lungs and digestive organs. It is most commonly seen in Caucasians. Only a few Chinese CF patients have been described in literature, taking into account the large population of China. The main objectives of this study are to accurately evaluate the prevalence of CF, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Fulfilled WHO clinical diagnostic criteria for CF; Was in a stable phase with no respiratory infections for nearly 4 weeks; Subjects (or their guardians) signed informed consent.
排除标准
- •Patients with other bronchiectasis who did not meet the inclusion criteria; Those with severe cardiac or renal disease
结局指标
主要结局
Change in spirometry (FEV1 and FVC) of lymphangioleiomyomatosis patients.
时间窗: 10 years
Spirometry will be evaluated at baseline and through study completion, an average of 3 years.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Clinical and Genetic Profile of Pediatric Patients With Cystic Fibrosis in Sohag.Cystic FibrosisNCT05599958Sohag University152
已完成
2 期
Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis PatientsCystic FibrosisNCT00499837Kamada, Ltd.21
Unknown
不适用
Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF).Adherence, MedicationCystic FibrosisNCT04215796Dosentrx Ltd.10
已完成
不适用
Biomarkers of Injury and Destruction in the Cystic Fibrosis LungCystic FibrosisNCT01805713University of Minnesota150
已完成
不适用
Benefits and Risks of Newborn Screening for Cystic FibrosisLung DiseasePseudomonas InfectionsCystic FibrosisNCT00014950National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
